US Stock MarketDetailed Quotes

Eupraxia Pharmaceuticals (EPRX)

Watchlist
  • 6.860
  • -0.220-3.11%
Close Apr 10 15:59 ET
  • 6.860
  • 0.0000.00%
Post 20:01 ET
421.91MMarket Cap-6.66P/E (TTM)

Eupraxia Pharmaceuticals (EPRX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
42.33%38.43M
116.03%16.16M
9.72%6.88M
26.07%8.26M
6.44%7.12M
-3.03%27M
-37.54%7.48M
-5.28%6.27M
14.81%6.56M
89.27%6.69M
Selling and administrative expenses
56.56%17.1M
130.44%8.3M
10.89%2.47M
18.75%3.07M
30.04%3.27M
45.96%10.92M
47.77%3.6M
19.29%2.22M
34.36%2.58M
99.55%2.52M
-General and administrative expense
56.56%17.1M
130.44%8.3M
10.89%2.47M
18.75%3.07M
30.04%3.27M
45.96%10.92M
47.77%3.6M
19.29%2.22M
34.36%2.58M
99.55%2.52M
Research and development costs
32.67%21.33M
102.67%7.87M
9.08%4.42M
30.83%5.2M
-7.80%3.85M
-21.04%16.08M
-59.32%3.88M
-14.90%4.05M
4.88%3.97M
83.57%4.18M
Operating profit
-42.33%-38.43M
-116.03%-16.16M
-9.72%-6.88M
-26.07%-8.26M
-6.44%-7.12M
3.03%-27M
37.54%-7.48M
5.28%-6.27M
-14.81%-6.56M
-89.27%-6.69M
Net non-operating interest income expense
153.88%1.41M
206.11%666.92K
-40.71%180.19K
114.40%255.96K
465.04%309.45K
281.11%556.37K
123.85%217.87K
340.06%303.89K
179.85%119.38K
34.00%-84.77K
Non-operating interest income
21.77%1.41M
205.92%666.92K
-40.80%180.19K
-36.21%255.96K
30.92%309.45K
34.41%1.16M
-38.38%218.01K
56.98%304.34K
163.49%401.23K
44.98%236.37K
Non-operating interest expense
--0
--0
--0
--0
--0
-48.42%603.57K
-99.95%137
-99.86%451
-6.60%281.85K
10.18%321.14K
Other net income (expense)
-322.19%-1.57M
-355.14%-1.21M
1,614.02%332.93K
-300.08%-733.96K
-91.97%50.29K
190.87%704.36K
-120.37%-266.79K
-101.19%-21.99K
110.06%366.83K
315.09%626.31K
Gain on sale of security
-250.05%-1.56M
-1,587.29%-1.21M
1,614.02%332.93K
-306.48%-733.96K
-91.80%51.36K
235.18%1.04M
-93.78%81.55K
-101.19%-21.99K
109.76%355.46K
315.19%626.31K
Special income (charges)
99.24%-2.56K
99.57%-1.49K
--0
--0
---1.08K
-6,853.59%-336.97K
-185,186.70%-348.34K
--0
351.50%11.37K
--0
-Less:Other special charges
----
----
----
----
----
--355.58K
----
----
----
----
-Gain on sale of property,plant,equipment
-113.77%-2.56K
-120.53%-1.49K
--0
--0
---1.08K
484.05%18.61K
3,952.66%7.24K
--0
351.50%11.37K
--0
Income before tax
-49.89%-38.59M
-121.90%-16.71M
-6.32%-6.37M
-44.05%-8.74M
-9.96%-6.76M
11.02%-25.74M
28.76%-7.53M
-22.37%-5.99M
36.16%-6.07M
-55.51%-6.15M
Income tax
958.26%19.09K
528.55%11.34K
-623
211.62%5.58K
-44.12%2.79K
-95.05%1.8K
1.8K
0
-5K
5K
Net income
-49.96%-38.61M
-121.99%-16.72M
-6.31%-6.37M
-44.26%-8.75M
-9.91%-6.77M
11.12%-25.74M
28.99%-7.53M
-22.37%-5.99M
36.21%-6.06M
-55.63%-6.16M
Net income continuous Operations
-49.96%-38.61M
-121.99%-16.72M
-6.31%-6.37M
-44.26%-8.75M
-9.91%-6.77M
11.12%-25.74M
28.99%-7.53M
-22.37%-5.99M
36.21%-6.06M
-55.63%-6.16M
Minority interest income
87.80%-29.51K
56.88%-10.08K
83.35%-7.99K
88.06%-6.77K
95.90%-4.67K
67.53%-241.95K
93.85%-23.39K
72.53%-48K
56.19%-56.68K
-87.65%-113.9K
Net income attributable to the parent company
-51.26%-38.58M
-122.55%-16.71M
-7.03%-6.36M
-45.51%-8.74M
-11.91%-6.76M
9.63%-25.5M
26.58%-7.51M
-25.88%-5.94M
35.94%-6.01M
-55.13%-6.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-51.26%-38.58M
-122.55%-16.71M
-7.03%-6.36M
-45.51%-8.74M
-11.91%-6.76M
9.63%-25.5M
26.58%-7.51M
-25.88%-5.94M
35.94%-6.01M
-55.13%-6.04M
Basic earnings per share
-35.53%-1.03
-68.18%-0.37
-11.76%-0.19
-52.94%-0.26
0.00%-0.21
35.04%-0.76
43.59%-0.22
5.56%-0.17
60.47%-0.17
-16.67%-0.21
Diluted earnings per share
-35.53%-1.03
-68.18%-0.37
-11.76%-0.19
-52.94%-0.26
0.00%-0.21
35.04%-0.76
43.59%-0.22
5.56%-0.17
60.47%-0.17
-16.67%-0.21
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 42.33%38.43M116.03%16.16M9.72%6.88M26.07%8.26M6.44%7.12M-3.03%27M-37.54%7.48M-5.28%6.27M14.81%6.56M89.27%6.69M
Selling and administrative expenses 56.56%17.1M130.44%8.3M10.89%2.47M18.75%3.07M30.04%3.27M45.96%10.92M47.77%3.6M19.29%2.22M34.36%2.58M99.55%2.52M
-General and administrative expense 56.56%17.1M130.44%8.3M10.89%2.47M18.75%3.07M30.04%3.27M45.96%10.92M47.77%3.6M19.29%2.22M34.36%2.58M99.55%2.52M
Research and development costs 32.67%21.33M102.67%7.87M9.08%4.42M30.83%5.2M-7.80%3.85M-21.04%16.08M-59.32%3.88M-14.90%4.05M4.88%3.97M83.57%4.18M
Operating profit -42.33%-38.43M-116.03%-16.16M-9.72%-6.88M-26.07%-8.26M-6.44%-7.12M3.03%-27M37.54%-7.48M5.28%-6.27M-14.81%-6.56M-89.27%-6.69M
Net non-operating interest income expense 153.88%1.41M206.11%666.92K-40.71%180.19K114.40%255.96K465.04%309.45K281.11%556.37K123.85%217.87K340.06%303.89K179.85%119.38K34.00%-84.77K
Non-operating interest income 21.77%1.41M205.92%666.92K-40.80%180.19K-36.21%255.96K30.92%309.45K34.41%1.16M-38.38%218.01K56.98%304.34K163.49%401.23K44.98%236.37K
Non-operating interest expense --0--0--0--0--0-48.42%603.57K-99.95%137-99.86%451-6.60%281.85K10.18%321.14K
Other net income (expense) -322.19%-1.57M-355.14%-1.21M1,614.02%332.93K-300.08%-733.96K-91.97%50.29K190.87%704.36K-120.37%-266.79K-101.19%-21.99K110.06%366.83K315.09%626.31K
Gain on sale of security -250.05%-1.56M-1,587.29%-1.21M1,614.02%332.93K-306.48%-733.96K-91.80%51.36K235.18%1.04M-93.78%81.55K-101.19%-21.99K109.76%355.46K315.19%626.31K
Special income (charges) 99.24%-2.56K99.57%-1.49K--0--0---1.08K-6,853.59%-336.97K-185,186.70%-348.34K--0351.50%11.37K--0
-Less:Other special charges ----------------------355.58K----------------
-Gain on sale of property,plant,equipment -113.77%-2.56K-120.53%-1.49K--0--0---1.08K484.05%18.61K3,952.66%7.24K--0351.50%11.37K--0
Income before tax -49.89%-38.59M-121.90%-16.71M-6.32%-6.37M-44.05%-8.74M-9.96%-6.76M11.02%-25.74M28.76%-7.53M-22.37%-5.99M36.16%-6.07M-55.51%-6.15M
Income tax 958.26%19.09K528.55%11.34K-623211.62%5.58K-44.12%2.79K-95.05%1.8K1.8K0-5K5K
Net income -49.96%-38.61M-121.99%-16.72M-6.31%-6.37M-44.26%-8.75M-9.91%-6.77M11.12%-25.74M28.99%-7.53M-22.37%-5.99M36.21%-6.06M-55.63%-6.16M
Net income continuous Operations -49.96%-38.61M-121.99%-16.72M-6.31%-6.37M-44.26%-8.75M-9.91%-6.77M11.12%-25.74M28.99%-7.53M-22.37%-5.99M36.21%-6.06M-55.63%-6.16M
Minority interest income 87.80%-29.51K56.88%-10.08K83.35%-7.99K88.06%-6.77K95.90%-4.67K67.53%-241.95K93.85%-23.39K72.53%-48K56.19%-56.68K-87.65%-113.9K
Net income attributable to the parent company -51.26%-38.58M-122.55%-16.71M-7.03%-6.36M-45.51%-8.74M-11.91%-6.76M9.63%-25.5M26.58%-7.51M-25.88%-5.94M35.94%-6.01M-55.13%-6.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -51.26%-38.58M-122.55%-16.71M-7.03%-6.36M-45.51%-8.74M-11.91%-6.76M9.63%-25.5M26.58%-7.51M-25.88%-5.94M35.94%-6.01M-55.13%-6.04M
Basic earnings per share -35.53%-1.03-68.18%-0.37-11.76%-0.19-52.94%-0.260.00%-0.2135.04%-0.7643.59%-0.225.56%-0.1760.47%-0.17-16.67%-0.21
Diluted earnings per share -35.53%-1.03-68.18%-0.37-11.76%-0.19-52.94%-0.260.00%-0.2135.04%-0.7643.59%-0.225.56%-0.1760.47%-0.17-16.67%-0.21
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Following the collapse of peace talks between the US and Iran, the US Central Command announced a full blockade of all vessels entering and Show More